Publications by authors named "Jessica Brehm"

Claim this Profile
O
Overrange dilution for improvement of hepatitis B core related antigen as a biomarker: protocol validation and examples for application.
Maria Pfefferkorn, Jessica Brehm, Martin Brehm, Fanny Honshoven, Danilo Deichsel

Virology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study.
Florian van Bömmel, Elisabetta Degasperi, Alena van Bömmel, Floriana Facchetti, Dana Sambarino, Jessica Brehm

Hepatol Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2.
Leoni Wey, Thomas Masetto, Alexander Spaeth, Jessica Brehm, Christian Kochem

Biomedicines· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients - a comparative long term post-infection study.
Jessica Brehm, Alexander Spaeth, Lars Dreßler, Thomas Masetto, Rainer Dannenberg

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription.
Afam A Okoye, Rémi Fromentin, Hiroshi Takata, Jessica H Brehm, Yoshinori Fukazawa

PLoS Pathog· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Diagnostic Performance of a Novel COVID-19 PETIA in Comparison to Four Routine N-, S- and RBD-Antigen Based Immunoassays.
Alexander Spaeth, Thomas Masetto, Jessica Brehm, Leoni Wey, Christian Kochem, Martin Brehm

Diagnostics (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo.
Christopher C Nixon, Maud Mavigner, Gavin C Sampey, Alyssa D Brooks, Rae Ann Spagnuolo, Jessica H Brehm

Nature· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4 T Cells.
Deanna A Kulpa, Aarthi Talla, Jessica H Brehm, Susan Pereira Ribeiro, Sally Yuan

J Virol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors.
Christina Gavegnano, Jessica H Brehm, Franck P Dupuy, Aarthi Talla, Susan Pereira Ribeiro

PLoS Pathog· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
Francesco Andrea Procopio, Rémi Fromentin, Deanna A Kulpa, Jessica H Brehm, Anne-Gaelle Bebin

EBioMedicine· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunological synapse: the gateway to the HIV reservoir.
Deanna A Kulpa, Jessica H Brehm, Rémi Fromentin, Anthony Cooper, Colleen Cooper

Immunol Rev· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors.
Jessica H Brehm, Dianna L Koontz, Carole L Wallis, Kathleen A Shutt, Ian Sanne

Clin Infect Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
Jessica H Brehm, Yanille Scott, Dianna L Koontz, Steven Perry, Scott Hammer

PLoS One· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase.
Jessica H Brehm, Christina M Lalama, Michael D Hughes, Richard Haubrich, Sharon A Riddler

J Acquir Immune Defic Syndr· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism by which a glutamine to leucine substitution at residue 509 in the ribonuclease H domain of HIV-1 reverse transcriptase confers zidovudine resistance.
Jessica H Brehm, John W Mellors, Nicolas Sluis-Cremer

Biochemistry· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
Jessica H Brehm, Dianna Koontz, Jeffrey D Meteer, Vinay Pathak, Nicolas Sluis-Cremer

J Virol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXAFS spectroscopic evidence for an Fe=O unit in the Fe(IV) intermediate observed during oxygen activation by taurine:alpha-ketoglutarate dioxygenase.
Pamela J Riggs-Gelasco, John C Price, Robert B Guyer, Jessica H Brehm, Eric W Barr

J Am Chem Soc· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis